Cargando…

Mast cell sarcoma: 2 Mayo Clinic cases

Detalles Bibliográficos
Autores principales:	Singh, Amritpal, Alkhateeb, Hassan, Pardanani, Animesh, He, Rong, Orazi, Attilio, Tefferi, Ayalew, Reichard, Kaaren K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2022
Materias:	Clinical Pearls in Blood Diseases
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543303/ https://www.ncbi.nlm.nih.gov/pubmed/35266568 http://dx.doi.org/10.1002/ajh.26525

Ejemplares similares

Pure (acute) erythroid leukemia: morphology, immunophenotype, cytogenetics, mutations, treatment details, and survival data among 41 Mayo Clinic cases
por: Reichard, Kaaren K., et al.
Publicado: (2022)

World Health Organization class-independent risk categorization in mastocytosis
por: Pardanani, Animesh, et al.
Publicado: (2019)

Cloak and dagger ‐ secondary hemophygocytic lymphohistiocytosis caused by intravenous autoinfection
por: Pircher, Andreas, et al.
Publicado: (2019)

Vaso‐occlusive crisis and acute chest syndrome in sickle cell disease due to 2019 novel coronavirus disease (COVID‐19)
por: Nur, Erfan, et al.
Publicado: (2020)

B‐cell lymphoblastic lymphoma with cutaneous involvement and a KMT2A gene rearrangement
por: Kemps, Paul G., et al.
Publicado: (2020)

Isolated congenital asplenia: An overlooked cause of thrombocytosis
por: Borsani, Oscar, et al.
Publicado: (2022)

Pseudoreticulocytosis in a patient with myelodysplastic syndrome
por: De Rossi, Noemy, et al.
Publicado: (2021)

Checkpoint inhibitor immunotherapy during pregnancy for relapsed–refractory Hodgkin lymphoma
por: Evens, Andrew M., et al.
Publicado: (2022)

Peripheral CD5+ CD10+ B‐cell proliferation with atypical morphology attributable to human herpesvirus 6 infection following umbilical cord blood transplantation
por: Canali, Alban, et al.
Publicado: (2022)

An unexpected finding during microscopy for urinary hemosiderin
por: Joshi, Nehal, et al.
Publicado: (2022)

A case of chronic neutrophilic leukemia and multiple myeloma showing the benefits of lenalidomide and cyclophosphamide therapy in treating both conditions
por: McVinnie, Kathryn, et al.
Publicado: (2022)

Granular B lymphoblastic leukemia
por: Hazarika, Biswadip, et al.
Publicado: (2022)

G6PD deficiency in patients identified as female
por: Bain, Barbara J., et al.
Publicado: (2022)

Myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T): Mayo-Moffitt collaborative study of 158 patients
por: Mangaonkar, Abhishek A., et al.
Publicado: (2022)

Training programs in blood diseases: Mayo Clinic Rochester Hematology–Oncology Fellowship Program
por: Chee, Cheng E, et al.
Publicado: (2010)

The Role of Mast Cells in the Defence against Pathogens
por: Urb, Mirjam, et al.
Publicado: (2012)

Momelotinib (JAK1/JAK2/ACVR1 inhibitor): mechanism of action, clinical trial reports, and therapeutic prospects beyond myelofibrosis
por: Tefferi, Ayalew, et al.
Publicado: (2023)

Influence of Mast Cells on Dengue Protective Immunity and Immune Pathology
por: St. John, Ashley L.
Publicado: (2013)

Erythrocytosis associated with EPAS1(HIF2A), EGLN1(PHD2), VHL, EPOR or BPGM mutations: the Mayo Clinic experience
por: Gangat, Naseema, et al.
Publicado: (2022)

Busulfan for the treatment of myeloproliferative neoplasms: the Mayo Clinic experience
por: Begna, K, et al.
Publicado: (2016)

Daunorubicin-60 versus daunorubicin-90 versus idarubicin-12 for induction chemotherapy in acute myeloid leukemia: a retrospective analysis of the Mayo Clinic experience
por: Tefferi, Ayalew, et al.
Publicado: (2022)

Mayo Clinic experience with 1123 adults with acute myeloid leukemia
por: Begna, Kebede H., et al.
Publicado: (2021)

JAK2 unmutated erythrocytosis: current diagnostic approach and therapeutic views
por: Gangat, Naseema, et al.
Publicado: (2021)

CPX-351 (Vyxeos™) treatment in blast-phase myeloproliferative neoplasm (MPN-BP): real-world experience in 12 consecutive cases
por: Ilyas, Rimal, et al.
Publicado: (2023)

Myelofibrosis Treatment Algorithm 2018
por: Tefferi, Ayalew, et al.
Publicado: (2018)

Myelofibrosis: Genetic Characteristics and the Emerging Therapeutic Landscape
por: Tefferi, Ayalew, et al.
Publicado: (2022)

Molecular and Cellular Mechanisms of KSHV Oncogenesis of Kaposi's Sarcoma Associated with HIV/AIDS
por: Cavallin, Lucas E., et al.
Publicado: (2014)

Blast phase myeloproliferative neoplasm with prior exposure to ruxolitinib: comparative analysis of mutations and survival
por: Abdelmagid, Maymona G., et al.
Publicado: (2023)

Clinical and prognostic impact of STAG2 mutations in myeloid neoplasms: the Mayo Clinic experience
por: Katamesh, Bahga, et al.
Publicado: (2022)

Primary breast sarcoma: clinicopathologic series from the Mayo Clinic and review of the literature
por: Adem, C, et al.
Publicado: (2004)

P580: CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH WT1 MUTATED MYELOID NEOPLASMS: MAYO CLINIC EXPERIENCE
por: Basmaci, Rami, et al.
Publicado: (2023)

P722: CHARACTERISATION OF PHF6 MUTATIONS IN MYELOID NEOPLASMS: THE MAYO CLINIC EXPERIENCE
por: Sai Mittapalli, Amrutha, et al.
Publicado: (2023)

P747: CLINICAL CHARACTERISTICS AND OUTCOME OF EZH2-MUTATED MYELOID NEOPLASMS: MAYO CLINIC EXPERIENCE
por: Oum, Muhamad, et al.
Publicado: (2023)

P734: CLONAL HEIRARCHY AND HETEROGENEITY IN STAG2M MYELOID NEOPLASMS: THE MAYO CLINIC EXPERIENCE
por: Katamesh, Bahga, et al.
Publicado: (2023)

Blast phase myeloproliferative neoplasm: Mayo-AGIMM study of 410 patients from two separate cohorts
por: Tefferi, Ayalew, et al.
Publicado: (2018)

Blast phase myeloproliferative neoplasm: contemporary review and 2024 treatment algorithm
por: Tefferi, Ayalew, et al.
Publicado: (2023)

Site‐specific venous thrombosis in essential thrombocythemia: Impact on subsequent vascular events and survival
por: Gangat, Naseema, et al.
Publicado: (2022)

A parasite’s take on the evolutionary cell biology of MICOS
por: Hashimi, Hassan
Publicado: (2019)

Validation of the WHO-defined 20% circulating blasts threshold for diagnosis of leukemic transformation in primary myelofibrosis
por: Mudireddy, Mythri, et al.
Publicado: (2018)

Marked elevation of serum lactate dehydrogenase in primary myelofibrosis: clinical and prognostic correlates
por: Shah, Sahrish, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_l0afopb3pgp9r9a78a079r9cv4